Sumitomo Pharma Co Ltd (4506.T) stock: key figures, P/E, revenue and dividend

Health Care · Japan · ISIN JP3495000006

Price
1,944.00 JPY
Market cap
846.86 bn JPY
P/E (2026)
7.92
P/S (2026)
1.87
Dividend yield
0.00 %
Net margin
23.58 %
Return on equity (ROE)
36.54 %
Return on assets (ROA)
13.28 %

Sumitomo Pharma Co Ltd financials

Fiscal year20252026
Revenue398.83 bn JPY453.29 bn JPY
Gross profit225.38 bn JPY256.89 bn JPY
EBIT22.42 bn JPY50.34 bn JPY
Net income23.63 bn JPY106.87 bn JPY
Diluted EPS – continuing operations59.49 JPY245.31 JPY

Full history since 1994, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Sumitomo Pharma Co Ltd

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.